KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Equity Ratio (2016 - 2025)

Biogen (BIIB) has 17 years of Equity Ratio data on record, last reported at 0.0 in Q3 2025.

  • For Q3 2025, Equity Ratio changed N/A year-over-year to 0.0; the TTM value through Sep 2025 reached 0.0, changed N/A, while the annual FY2024 figure was 0.6, 8.1% up from the prior year.
  • Equity Ratio reached 0.0 in Q3 2025 per BIIB's latest filing, down from 0.62 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.62 in Q2 2025 and bottomed at 0.0 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.5, with a median of 0.55 recorded in 2022.
  • Peak YoY movement for Equity Ratio: dropped 6.87% in 2021, then grew 21.53% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.46 in 2021, then grew by 18.79% to 0.55 in 2022, then rose by 1.11% to 0.55 in 2023, then rose by 8.1% to 0.6 in 2024, then tumbled by 100.1% to 0.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.0 in Q3 2025, 0.62 in Q2 2025, and 0.61 in Q1 2025.